PerkinElmer to Showcase Expanded Life Science / Cell & Gene Therapy Portfolios and Automated Genomic Workflows at SLAS 2022
End-to-end solutions designed to help scientists streamline and improvedrug discovery R&D productivity WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, is at SLAS 2022 on February 7-9 along with several of its new partner companies showcasing how its end-to-end life science solutions and automated workflows can accelerate scientists’ R&D productivity... Read more